Biologics Nonclinical Drug Development Course

Includes a Live In-Person Event on 06/14/2027 at 8:00 AM (EDT)

  • You must log in to register
    • Early bird pricing available!
    • Nonmember - $1,950
    • Full Member - $1,650
    • Associate Member - $1,650
    • Emeritus Member - $1,650
    • Government Associate Member - $1,650
    • Government Full Member - $1,650
    • Postdoctoral Researcher/Transitional Member - $895
    • Student Member - $895
    • Regular Price after 04/22/2027 11:59 PM
    • Nonmember - $2,050
    • Full Member - $1,750
    • Associate Member - $1,750
    • Emeritus Member - $1,750
    • Government Associate Member - $1,750
    • Government Full Member - $1,750
    • Postdoctoral Researcher/Transitional Member - $995
    • Student Member - $995

This ACT course offers an in-depth exploration of regulatory considerations and the toxicologic evaluation and development of protein biologics, modified protein biologics, and specialized biologics, including cell and gene therapies, and oncolytic viruses. Participants gain a thorough understanding of the key principles and methodologies employed in the nonclinical safety assessment of these advanced therapeutic modalities. The curriculum covers a wide range of studies essential for advancing biotherapeutic drug candidates through all stages of drug development from candidate selection to marketing authorization. Topics include general toxicity studies and a variety of specialized studies, such as off-target assessment, safety pharmacology, carcinogenicity, and reproductive and developmental toxicity studies. Additionally, the course provides insight into pharmacokinetic and biodistribution assessments and the potential impact of immunogenicity for various of different therapeutic modalities. Several case studies are used to highlight how specific strategies and issues are approached in different scenarios.

The course will be held in Gaithersburg, Maryland, from June 14–16, 2027. More information about the schedule and registration will be available soon.

This ACT course is offered exclusively in person. Virtual or hybrid participation options are not available.

This content will not be available until 11/30/2026 at 9:00 AM (EST)